WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Noise-Induced Hearing Loss-Acute Exposure Treatment

Phase 2

Terminated

Conditions: Hearing Loss, Noise-Induced

Interventions: Drug: Zonisamide 100Mg Cap
Drug: Placebo

First Posted Date: 2021-02-24

Last Posted Date: 2023-10-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 24

Registration Number: NCT04768569

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Implementation of Genomics in Substance Use Disorder Treatment

Not Applicable

Completed

Conditions: Tobacco Use Cessation
Tobacco Use Disorder
Smoking Cessation

Interventions: Behavioral: Genetically-Informed RiskProfile
Other: Brief Cessation Advice

First Posted Date: 2021-02-24

Last Posted Date: 2024-01-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 148

Registration Number: NCT04768114

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes

Not Applicable

Active, not recruiting

Conditions: Virus Diseases
Enterovirus Infections
Heart Defects, Congenital
Heart Diseases
Diabetes Mellitus, Type 2
Pregnancy Complications
Congenital Heart Disease
Prenatal Infection
Diabetes Mellitus, Type 1
Diabetes Mellitus

Interventions: Other: Stool and Blood Specimen Collection
Other: Follow-up Medical Record Review

First Posted Date: 2021-02-24

Last Posted Date: 2024-04-23

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1500

Registration Number: NCT04769167

Locations: 🇺🇸
St Louis Childrens Hospital, Saint Louis, Missouri, United States
🇺🇸
Barnes Jewish Hospital, Saint Louis, Missouri, United States

Video Education for Labor and Delivery

Not Applicable

Completed

Conditions: Educational Problems
Pregnancy Related

Interventions: Other: Childbirth Educational Video

First Posted Date: 2021-02-23

Last Posted Date: 2022-12-12

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 161

Registration Number: NCT04766099

Locations: 🇺🇸
Barnes Jewish Hospital, Saint Louis, Missouri, United States

Evaluating Implementation and Scale-Up of Nigeria's National Sodium Reduction Program

Recruiting

Conditions: Population Sodium Intake
Dietary Sources of Sodium

Interventions: Other: SHAKE Package

First Posted Date: 2021-02-23

Last Posted Date: 2024-12-18

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1350

Registration Number: NCT04765865

Locations: 🇳🇬
Federal Medical Centre, Abeokuta, Ogun, Nigeria
🇳🇬
University of Abuja Teaching Hospital, Gwagwalada, Nigeria
🇳🇬
Aminu Kano Teaching Hospital, Kano, Nigeria

Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma

Phase 1

Completed

Conditions: Astrocytoma, Grade III
Grade IV Astrocytoma
Grade III Astrocytoma
Astrocytoma, Grade IV

Interventions: Drug: Tadalafil

First Posted Date: 2021-02-17

Last Posted Date: 2023-06-13

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 18

Registration Number: NCT04757662

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

89Zr-Trastuzumab PET/CT in Subjects With Previously Treated HER2-Positive Solid Tumors Scheduled to Receive Treatment With MT-5111

Phase 2

Withdrawn

Conditions: HER2-positive Solid Tumor
HER-2 Positive Cancer

Interventions: Drug: 89Zr-trastuzumab

First Posted Date: 2021-02-16

Last Posted Date: 2021-12-23

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT04757090

Safety and Efficacy of Combining APL-101 With Frontline Osimertinib in Patients With EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)

Phase 1

Recruiting

Conditions: Metastatic Non Small Cell Lung Cancer

Interventions: Drug: APL-101
Drug: Osimertinib

First Posted Date: 2021-02-08

Last Posted Date: 2024-11-26

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 25

Registration Number: NCT04743505

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant

Phase 1

Recruiting

Conditions: Myelodysplastic Syndromes

Interventions: Drug: DEC-C
Device: MyeloSeq-HD

First Posted Date: 2021-02-08

Last Posted Date: 2023-09-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 126

Registration Number: NCT04742634

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Interactive Self-Management Augmented by Rehabilitation Technologies

Not Applicable

Completed

Conditions: Epidemiology
Neurologic Disorder
Occupational Therapy

Interventions: Behavioral: iSMART

First Posted Date: 2021-02-08

Last Posted Date: 2021-08-30

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 24

Registration Number: NCT04743037

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy